Related Experiment Video
Updated: Jun 4, 2025

09:08
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
1.8K
Class B Scavenger Receptor CD36 as a Potential Therapeutic Target in Inflammation Induced by Danger-Associated
Irina N Baranova1, Alexander V Bocharov1, Tatyana G Vishnyakova1
1Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
Cells
|December 17, 2024
Summary
The scavenger receptor CD36 acts as a pattern recognition receptor (PRR), mediating inflammatory responses to danger-associated molecular patterns (DAMPs). Blocking CD36 reduces DAMP-induced inflammation, highlighting its therapeutic potential.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- The scavenger receptor CD36 binds lipids and acts as a pattern recognition receptor (PRR) for pathogens.
- Danger-Associated Molecular Patterns (DAMPs) are endogenous molecules released during cellular stress or injury that can trigger immune responses.
Purpose of the Study:
- To investigate the role of CD36 as a PRR in mediating pro-inflammatory effects of DAMPs.
- To evaluate CD36's involvement in DAMP-induced cytokine production and inflammatory signaling.
Main Methods:
- Assessed IL-8 and IL-6 cytokine responses in CD36-overexpressing HEK293 cells and CD36-deficient bone marrow-derived macrophages (BMDM).
- Utilized various DAMPs (HMGB1, HSPs, histone H3, SAA, oxPAPC) and cell/tissue lysates.
- Tested the inhibitory effect of synthetic amphipathic helical peptides (SAHPs) on CD36-dependent inflammation.
- Evaluated in vivo inflammatory responses in mice via IP injection of cellular lysates and measurement of pro-inflammatory markers.
Main Results:
- CD36 overexpression significantly enhanced IL-8 responses to DAMPs and lysates (~7-10-fold).
- DAMP-induced IL-6 secretion was reduced in CD36-deficient BMDM (~2-3 times).
- SAHPs blocked CD36-dependent inflammatory responses.
- In vivo inflammatory markers in liver and lung were reduced by ~50% in CD36-deficient mice.
Conclusions:
- CD36 functions as a PRR mediating innate immune responses to DAMPs.
- CD36 plays a significant role in DAMP-induced inflammatory signaling.
- CD36 represents a potential therapeutic target for DAMP-associated inflammatory conditions.

